263 related articles for article (PubMed ID: 17880337)
1. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up.
Egred M; Andron M; Albouaini K; Alahmar A; Grainger R; Morrison WL
J Interv Cardiol; 2007 Oct; 20(5):395-401. PubMed ID: 17880337
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
[TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
[TBL] [Abstract][Full Text] [Related]
4. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience.
Aytemir K; Oto A; Ozkutlu S; Kaya EB; Canpolat U; Yorgun H; Sahiner L; Kabakçi G
J Interv Cardiol; 2012 Aug; 25(4):375-81. PubMed ID: 22612236
[TBL] [Abstract][Full Text] [Related]
5. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale.
Freixa X; Ibrahim R; Chan J; Garceau P; Dore A; Marcotte F; Mercier LA; Mongeon FP; Basmadjian A; Khairy P; Asgar AW
EuroIntervention; 2013 Sep; 9(5):629-35. PubMed ID: 24058079
[TBL] [Abstract][Full Text] [Related]
7. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
[TBL] [Abstract][Full Text] [Related]
8. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
9. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous closure of atrial septal defects: a decade of experience at a reference center.
Fiarresga A; De Sousa L; Martins JD; Ramos R; Paramés F; Freitas I; Oliveira JA; Trigo C; Agapito A; Ferreira RC; Pinto F
Rev Port Cardiol; 2010 May; 29(5):767-80. PubMed ID: 20866006
[TBL] [Abstract][Full Text] [Related]
11. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous patent foramen ovale and atrial septal defect closure in adults: results and device comparison in 100 consecutive implants at a single center.
Herrmann HC; Silvestry FE; Glaser R; See V; Kasner S; Bradbury D; Chang G; Hirshfeld JW; Horwitz PA; Kelly M
Catheter Cardiovasc Interv; 2005 Feb; 64(2):197-203. PubMed ID: 15678448
[TBL] [Abstract][Full Text] [Related]
13. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
[TBL] [Abstract][Full Text] [Related]
15. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
Wahl A; Tai T; Praz F; Schwerzmann M; Seiler C; Nedeltchev K; Windecker S; Mattle HP; Meier B
JACC Cardiovasc Interv; 2009 Feb; 2(2):116-23. PubMed ID: 19463412
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of atrial septal defects: immediate and mid-term results.
Dardas PS; Ninios VN; Mezilis NE; Tsikaderis DD; Thanopoulos VD
Hellenic J Cardiol; 2010; 51(2):104-12. PubMed ID: 20378511
[TBL] [Abstract][Full Text] [Related]
17. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale.
Schoen SP; Boscheri A; Lange SA; Braun MU; Fuhrmann J; Kappert U; Strasser RH
Heart; 2008 Jul; 94(7):844-7. PubMed ID: 18070946
[TBL] [Abstract][Full Text] [Related]
18. Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patients.
Medford BA; Taggart NW; Cabalka AK; Cetta F; Reeder GS; Hagler DJ; Johnson JN
J Am Soc Echocardiogr; 2014 Sep; 27(9):984-90. PubMed ID: 24998516
[TBL] [Abstract][Full Text] [Related]
19. Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
Becker M; Frings D; Schröder J; Ocklenburg C; Mühler E; Hoffmann R; Franke A; Lepper W
J Interv Cardiol; 2009 Dec; 22(6):503-10. PubMed ID: 19821880
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous treatment of patent foramen ovale and atrial septal defects.
Tobis J; Shenoda M
J Am Coll Cardiol; 2012 Oct; 60(18):1722-32. PubMed ID: 23040567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
